Cargando…

Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis

BACKGROUND: Severe combined immunodeficiency (SCID) syndromes are a heterogenous group of diseases characterized by impairment in both cellular and humoral immunity with a range of genetic disorders. Complete recombinase activating gene (RAG) deficiency is associated with classical T(-)B(-)NK(+) SCI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulusoy, Ezgi, Karaca, Neslihan Edeer, Azarsiz, Elif, Berdeli, Afig, Aksu, Guzide, Kutukculer, Necil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817577/
https://www.ncbi.nlm.nih.gov/pubmed/27081423
http://dx.doi.org/10.14740/jocmr2316w
_version_ 1782424913945034752
author Ulusoy, Ezgi
Karaca, Neslihan Edeer
Azarsiz, Elif
Berdeli, Afig
Aksu, Guzide
Kutukculer, Necil
author_facet Ulusoy, Ezgi
Karaca, Neslihan Edeer
Azarsiz, Elif
Berdeli, Afig
Aksu, Guzide
Kutukculer, Necil
author_sort Ulusoy, Ezgi
collection PubMed
description BACKGROUND: Severe combined immunodeficiency (SCID) syndromes are a heterogenous group of diseases characterized by impairment in both cellular and humoral immunity with a range of genetic disorders. Complete recombinase activating gene (RAG) deficiency is associated with classical T(-)B(-)NK(+) SCID which is the most common phenotype of Turkish SCID patients. There is a broad spectrum of hypomorfic RAG mutations including Omenn syndrome, leaky or atypical SCID with expansion of γδ T cells, autoimmunity and cytomegalovirus (CMV) infections. METHODS: Twenty-one (44%) patients had RAG1 deficiency of all 44 SCID patients followed up by pediatric immunology department. A retrospective analysis was conducted on the medical records of all SCID patients with RAG1 deficiency. RESULTS: Eight patients were classified as T(-)B(-)NK(+) SCID, five patients as T(+)B(-)NK(+) SCID (three of these were Omenn phenotype), and eight patients as T(+)B(+)NK(+) SCID phenotype. Mean age of the whole study group, mean age at onset of symptoms and mean age at diagnosis were 87.7 ± 73.8 (12 - 256), 4.4 ± 8.2 (1 - 36) and 29.1 ± 56.8 (1 - 244) months, respectively. Consanguinity was present in 11 (52%) of 21 patients. Autoimmunity was found in six patients (28%). Ten patients (47%) had CMV infection, four (19%) had Epstein-Barr virus (EBV) infections and three (14%) had Bacillus Calmette-Guerin (BCG) infections. Seven patients who had refractory cytopenia (two pancytopenia and five bicytopenia) underwent bone marrow biopsy, three of whom had bone marrow fibrosis. Future evaluations must be considered about bone marrow fibrosis in RAG1 deficiency patients. Eosinophilia was observed in 10 patients, seven of whom did not have Omenn phenotype. CONCLUSION: Non-Omenn phenotype RAG1 deficiencies can also present with eosinophilia. This report is presented to emphasize that RAG1 mutations may lead to diverse clinical phenotypes.
format Online
Article
Text
id pubmed-4817577
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-48175772016-04-14 Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis Ulusoy, Ezgi Karaca, Neslihan Edeer Azarsiz, Elif Berdeli, Afig Aksu, Guzide Kutukculer, Necil J Clin Med Res Original Article BACKGROUND: Severe combined immunodeficiency (SCID) syndromes are a heterogenous group of diseases characterized by impairment in both cellular and humoral immunity with a range of genetic disorders. Complete recombinase activating gene (RAG) deficiency is associated with classical T(-)B(-)NK(+) SCID which is the most common phenotype of Turkish SCID patients. There is a broad spectrum of hypomorfic RAG mutations including Omenn syndrome, leaky or atypical SCID with expansion of γδ T cells, autoimmunity and cytomegalovirus (CMV) infections. METHODS: Twenty-one (44%) patients had RAG1 deficiency of all 44 SCID patients followed up by pediatric immunology department. A retrospective analysis was conducted on the medical records of all SCID patients with RAG1 deficiency. RESULTS: Eight patients were classified as T(-)B(-)NK(+) SCID, five patients as T(+)B(-)NK(+) SCID (three of these were Omenn phenotype), and eight patients as T(+)B(+)NK(+) SCID phenotype. Mean age of the whole study group, mean age at onset of symptoms and mean age at diagnosis were 87.7 ± 73.8 (12 - 256), 4.4 ± 8.2 (1 - 36) and 29.1 ± 56.8 (1 - 244) months, respectively. Consanguinity was present in 11 (52%) of 21 patients. Autoimmunity was found in six patients (28%). Ten patients (47%) had CMV infection, four (19%) had Epstein-Barr virus (EBV) infections and three (14%) had Bacillus Calmette-Guerin (BCG) infections. Seven patients who had refractory cytopenia (two pancytopenia and five bicytopenia) underwent bone marrow biopsy, three of whom had bone marrow fibrosis. Future evaluations must be considered about bone marrow fibrosis in RAG1 deficiency patients. Eosinophilia was observed in 10 patients, seven of whom did not have Omenn phenotype. CONCLUSION: Non-Omenn phenotype RAG1 deficiencies can also present with eosinophilia. This report is presented to emphasize that RAG1 mutations may lead to diverse clinical phenotypes. Elmer Press 2016-05 2016-03-20 /pmc/articles/PMC4817577/ /pubmed/27081423 http://dx.doi.org/10.14740/jocmr2316w Text en Copyright 2016, Ulusoy et al. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ulusoy, Ezgi
Karaca, Neslihan Edeer
Azarsiz, Elif
Berdeli, Afig
Aksu, Guzide
Kutukculer, Necil
Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis
title Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis
title_full Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis
title_fullStr Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis
title_full_unstemmed Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis
title_short Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis
title_sort recombinase activating gene 1 deficiencies without omenn syndrome may also present with eosinophilia and bone marrow fibrosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817577/
https://www.ncbi.nlm.nih.gov/pubmed/27081423
http://dx.doi.org/10.14740/jocmr2316w
work_keys_str_mv AT ulusoyezgi recombinaseactivatinggene1deficiencieswithoutomennsyndromemayalsopresentwitheosinophiliaandbonemarrowfibrosis
AT karacaneslihanedeer recombinaseactivatinggene1deficiencieswithoutomennsyndromemayalsopresentwitheosinophiliaandbonemarrowfibrosis
AT azarsizelif recombinaseactivatinggene1deficiencieswithoutomennsyndromemayalsopresentwitheosinophiliaandbonemarrowfibrosis
AT berdeliafig recombinaseactivatinggene1deficiencieswithoutomennsyndromemayalsopresentwitheosinophiliaandbonemarrowfibrosis
AT aksuguzide recombinaseactivatinggene1deficiencieswithoutomennsyndromemayalsopresentwitheosinophiliaandbonemarrowfibrosis
AT kutukculernecil recombinaseactivatinggene1deficiencieswithoutomennsyndromemayalsopresentwitheosinophiliaandbonemarrowfibrosis